Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Shanghai Institute of Gut Microbiota Research and Engineering Development is a biotechnology organization focused on the research and commercialization of gut microbiome-based interventions. Founded by leading experts in the field, the institute specializes in identifying specific gut bacteria that influence human health, particularly in metabolic diseases like obesity and diabetes. They develop personalized nutritional programs and live biotherapeutic products designed to modulate the gut ecosystem. The company bridges the gap between academic research and industrial application, providing diagnostic services and targeted probiotic formulations. Their work is heavily based on the core microbiota theory and high-throughput sequencing technologies to restore healthy microbial balance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Institution of Gut Microbiota Research and Engineering Development.